Novartis (VTX:NOVN)
The merger of Ciba-Geigy and Sandoz in 1996 gave rise to Novartis, now the world's 3rd largest pharmaceutical group. Despite its relative youth, the Basel-based company presents an attractive profile for investors, with a dividend yield of 3% and steadily increasing payouts.
Novartis (VTX:NOVN) Read More »